We know that the Lymphoedema surveillance and prevention model is best practice.
This model of care has been proven effective in several research articles and is supported by many international groups in their position statements and consensus documents, including;
– The International Lymphoedema Framework
– Australian Lymphoedema Association
– National Lymphoedema Network
So WHY are we not able to do more in the UK?
In this webinar we will be speaking to two of the leading pioneers for this pathway in the UK and internationally to discuss and explore the barriers we face implementing this pathway and what we can do to overcome them.
Ali Batchelor – Lead Lymphoedema Nurse Specialist at Yeovil and Taunton Lymphoedema
Ali has been working in the field of Lymphoedema since 2002 and for the past 12 years has led the Lymphoedema service for Somerset. They accept both cancer and non-cancer referrals with a caseload of approximately 1500 patients.
Ali’s passion and special interest is Lymphoedema prevention. She has pioneered this in Somerset and has been using Bioimpedence to monitor high risk breast cancer patients since 2009 and, more recently, Gynae and malignant melanoma patients.
Louise Koelmeyer – Lymphoedema Specialist, Director & Senior Lecturer, ALERT Program, Macquarie University, Australia.
Louise is an occupational and Lymphoedema therapist, educator and researcher with over 30 years of experience in both public and private settings specialising in breast cancer rehabilitation and Lymphoedema management.
Louise is involved in strategically managing and developing the education, research and treatment arms of the innovative multidisciplinary program. Her particular area of interest is on the prospective surveillance and early intervention model of care for the early detection and management of Lymphoedema as well as innovative advances in conservative and surgical management.